Certara

About

Certara is a pharmaceutical company that accelerates medicines with biosimulation software and technology.

Princeton,New Jersey,United States
1001 - 5000
https://www.certara.com

Highlights

Details

Last Funding Type: Post-IPO Secondary
Last Funding Money Raised: $449M
Industries: Biotechnology,Health Care,Pharmaceutical,Software
Founded date: Jan 1, 2008
Number Of Employee: 1001 - 5000
Operating Status: Active
Stock Symbol: nasdaq:CERT
Legal Name: Certara, Inc.

Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Certara's end-to-end platform includes biosimulation, regulatory science, and market access solutions. It integrates its unique portfolio of software and technology-enabled services spanning discovery to post-approval.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$1.50B

Certara has raised a total of $1.50B in funding over 2 rounds. Their latest funding was raised on Nov 7, 2022 from a Post-IPO Secondary round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 7, 2022	Post-IPO Secondary	$449M	1	Arsenal Capital Partners	—	Detail
Sep 20, 2021	Grant	—	1	—	—	Detail
Sep 13, 2021	Post-IPO Equity	$139.50M	—	—	—	Detail
Mar 25, 2021	Post-IPO Equity	$250M	1	Mubadala	—	Detail
Dec 10, 2020	IPO	$668.26M	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

3

Certara is funded by 3 investors. Arsenal Capital Partners and Mubadala are the most recent investors.

Investor Name	Lead Investor	Funding Round
Arsenal Capital Partners	Yes	Post-IPO Secondary
Mubadala	Yes	Post-IPO Equity
U.S. Food and Drug Administration	—	Grant

Employee Profiles

Number of Employee Profiles

11

Certara has 11 current employee profiles, including Board member Mason Slaine

Board member

Executive

Executive

Executive

Executive

Acquisition

Certara has acquired 8 organizations. Their most recent acquisition was Tripos International on Jan 1, 2008. They acquired Tripos International for 0.

Date Company Name	Industry	Acquisition Type	Price
Jan 1, 2008 Tripos International	Biotechnology	acquisition	—	Detail
Mar 13, 2012 Simcyp	Health Care	acquisition	—	Detail
Aug 13, 2013 Great Lakes Drug Development	Health Care	acquisition	—	Detail
Apr 5, 2014 Synchrogenix	Biotechnology	acquisition	—	Detail
Dec 1, 2015 XenologiQ	Biotechnology	acquisition	—	Detail